Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v2-FR | Version v1-EN | |
---|---|---|
Language | French | English |
Date Updated | 2020-04-03 | 2020-04-03 |
Drug Identification Number | 00532657 | 00532657 |
Brand name | TEVA-TRIAMTERENE/HCTZ | TEVA-TRIAMTERENE/HCTZ |
Common or Proper name | TEVA-TRIAMTERENE HCTZ 50/25MG TABS | TEVA-TRIAMTERENE HCTZ 50/25MG TABS |
Company Name | TEVA CANADA LIMITED | TEVA CANADA LIMITED |
Ingredients | TRIAMTERENE HYDROCHLOROTHIAZIDE | TRIAMTERENE HYDROCHLOROTHIAZIDE |
Strength(s) | 50MG 25MG | 50MG 25MG |
Dosage form(s) | TABLET | TABLET |
Route of administration | ORAL ORAL | ORAL ORAL |
Packaging size | 500's | 500's |
ATC code | C03EA | C03EA |
ATC description | DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB | DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB |
Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
Anticipated start date | ||
Actual start date | 2020-04-01 | 2020-04-01 |
Estimated end date | Unknown | Unknown |
Actual end date | ||
Shortage status | Actual shortage | Actual shortage |
Tier 3 Status | No | No |
Company comments | Pack size to be discontinued | Pack size to be discontinued |
Health Canada comments |